Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Intracellular Th stock

Learn how to easily invest in Intracellular Th stock.

Intracellular Th is a drug manufacturers-specialty & generic business based in the US. Intracellular Th shares (ITCI) are listed on the NASDAQ and all prices are listed in US Dollars. Intracellular Th employs 512 staff and has a trailing 12-month revenue of around $138.5 million.

How to buy shares in Intracellular Th

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ITCI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Intracellular Th stock price (NASDAQ: ITCI)

Use our graph to track the performance of ITCI stocks over time.

Intracellular Th shares at a glance

Information last updated 2022-09-26.
Latest market close$46.53
52-week range$34.43 - $66.00
50-day moving average $52.31
200-day moving average $53.05
Wall St. target price$70.17
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-3.61

Buy Intracellular Th shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Intracellular Th stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Intracellular Th price performance over time

Historical closes compared with the close of $46.53 from 2022-09-30

1 week (2022-09-23) 6.94%
1 month (2022-09-02) -9.84%
3 months (2022-07-01) -15.66%
6 months (2022-04-01) -25.77%
1 year (2021-10-01) 20.98%
2 years (2020-10-02) 95.42%
3 years (2019-10-02) 491.98%
5 years (2017-10-02) 200.00%

Intracellular Th financials

Revenue TTM $138.5 million
Gross profit TTM $-13,077,085
Return on assets TTM -28.16%
Return on equity TTM -50.38%
Profit margin -232.11%
Book value $7.65
Market capitalisation $4.1 billion

TTM: trailing 12 months

Intracellular Th share dividends

We're not expecting Intracellular Th to pay a dividend over the next 12 months.

Intracellular Th share price volatility

Over the last 12 months, Intracellular Th's shares have ranged in value from as little as $34.43 up to $66. A popular way to gauge a stock's volatility is its "beta".

ITCI.US volatility(beta: 1.19)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Intracellular Th's is 1.1878. This would suggest that Intracellular Th's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Intracellular Th overview

Intra-Cellular Therapies, Inc. , a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for the treatment of bipolar depression, as well as to treat autism spectrum disorder; and in additional neuropsychiatric indications, such as sleep disorders associated with neuropsychiatric and neurological disorders. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease and heart failure; ITI-1284-ODT-SL for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York.

Frequently asked questions

What percentage of Intracellular Th is owned by insiders or institutions?
Currently 2.453% of Intracellular Th shares are held by insiders and 92.648% by institutions.
How many people work for Intracellular Th?
Latest data suggests 512 work at Intracellular Th.
When does the fiscal year end for Intracellular Th?
Intracellular Th's fiscal year ends in December.
Where is Intracellular Th based?
Intracellular Th's address is: 430 East 29th Street, New York, NY, United States, 10016
What is Intracellular Th's ISIN number?
Intracellular Th's international securities identification number is: US46116X1019
What is Intracellular Th's CUSIP number?
Intracellular Th's Committee on Uniform Securities Identification Procedures number is: 46116X101

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site